- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT04291833
Prospective, Assessment of Vitamin D and Calcium Supplementation, Improvement of Nutritional Status and Preoperative Rehabilitation in Patients Before Knee Arthroplasty.
Prospective randomized study of 150 patients qualified for knee arthroplasty between 2015 and 2017. Patients were randomized into 3 groups receiving vitamin D and calcium supplementation, increased protein supply and preoperative rehabilitation, respectively.
Following factors were analyzed: changes in vitamin D3, calcium, total protein, albumin and CRP levels during preparation for surgery, nutritional status on the Subjective Global Assessment (SGA) scale, osteoporosis risk assessment according to the Osteoporosis Risk SCORE, level of pain felt on the scale VAS and the number of analgesics used, the result of the Duke Activity Status Index, the result of the following scales: Cardiac Risk Index for Orthopedic Surgery (Lee), Knee injury and Osteoarthritis Outcome Score (KOOS), Fear Avoidance Beliefs Questionnaire (FABQ) about Physical Activity, The Quality of Life Scale (QOLS). Additionally, the occurrence of perioperative complications was analyzed (e.g. venous thrombosis and pulmonary embolism, wound or joint infection, excessive bleeding, loosening of the implant, bone fracture or fracture, pain).
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Malopolska
-
Kraków, Malopolska, Polonia, 31-559
- Bartlomiej Szpyra
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- with a disease lasting more than 5 years and without total limitation of physical fitness,
- reporting pain> 5 on the VAS scale (Visual Analogue Scale)
- general fitness according to the ASA (Amercican Society of Anestesiology) scale up to 3
Exclusion Criteria:
- patients with metabolic and systemic disorders with contraindications for calcium substitution, vitamin D3 and protein supply,
- intolerance of physical effort> 2, 5 MET (Metabolic Equivalent of Task)
- limitation of the degree overall efficiency> 3 in the ASA classification
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Comparador activo: Intervention group 1
Protein supplementation BID, Vitamin D and calcium supplementation Vitamin D 2000 IU / d, calcium 1000mg/d, exercise 6 months
|
Protein supplementation BID, Vitamin D and calcium supplementation Vitamin D 2000 IU / d, calcium 1000mg/d, exercise 6 months
|
Comparador activo: Intervention group 2
Protein supplementation QD, Vitamin D and calcium supplementation Vitamin D 1000 IU / d, calcium 500mg/d, exercise 3 months
|
Protein supplementation QD, Vitamin D and calcium supplementation Vitamin D 1000 IU / d, calcium 500mg/d, exercise 3 months
|
Comparador de placebos: Control group 0
no protein supplementation , no Vitamin D and calcium supplementation , no exercise
|
no protein supplementation , no Vitamin D and calcium supplementation , no exercise
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Pain control satisfaction assessed on the Visual Analogue Scale (VAS)
Periodo de tiempo: 18 months
|
Visual Analogue Scale (VAS) is a measure determining the intensity of pain by means of a visual analogue scale.
Subject is marking the examined point on a line of 10 cm long, where the value 0 is assigned the total absence of pain, and 10 the strongest pain that can be imagined.
|
18 months
|
Vitamin D concentration in blood, based on laboratory analysis.
Periodo de tiempo: 18 months
|
Concentration of vitamin D in blood is a laboratory parameter, measured in unit of ng/ml.
Levels below 20 ng/ml is a severe vitamin D deficiency condition that requires treatment.
The result in the range 20-30 ng/ml means that the vitamin level is not sufficient.
Values between 30-50 ng/ml are considered normal.
This is one of the basic laboratory parameters for assessing the body's bone mineral metabilism.
|
18 months
|
Efficiency of the knee joint assessed on The Knee Injury and Osteoarthritis Outcome Score (KOOS) scale.
Periodo de tiempo: 18 months
|
The Knee Injury and Osteoarthritis Outcome Score (KOOS) is a questionnaire designed to assess short and long-term patient-relevant outcomes following knee injury.
The KOOS is self-administered and assesses five outcomes: pain, symptoms, activities of daily living, sport and recreation function, and knee-related quality of life.
Scores are transformed to a 0-100 scale, with zero representing extreme knee problems and 100 representing no knee problems as common in orthopaedic scales and generic measures.
Scores between 0 and 100 represent the percentage of total possible score achieved.
|
18 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Calcium ionized concentration in blood, based on laboratory analysis.
Periodo de tiempo: 18 months
|
Calcium ionized concentration in blood is a laboratory parameter, measured in unit of mmol/l.
The results below 1.16 mmol/l mean that the level is not sufficient, condition called hypocalcemia.
Values between 1.16-1.32
mmol/l are considered normal.
The results above 1.32 mmol/l mean hypercalcemia occurs.
This is one of the basic laboratory parameters for assessing the body's bone mineral metabilism.
|
18 months
|
Total protein concentration in blood, based on laboratory analysis.
Periodo de tiempo: 18 months
|
Total protein concentration in blood is a laboratory parameter, measured in unit of g/l.
The results below 60 g/l mean that the level is not sufficient, condition called hypoproteinemia.
Values between 60-80 g/l are considered normal.
The results above 80 g/l mean hyperproteinemia occurs.
This is one of the basic laboratory parameters for assessing the body's nutritional status.
|
18 months
|
Albumin concentration in blood, based on laboratory analysis
Periodo de tiempo: 18 months
|
Albumin concentration in blood is a laboratory parameter, measured in unit of mg/ml.
The results below 35 mg/l mean that the level is not sufficient, condition called hypoalbuminemia.
Values between 35-50 mg/ml are considered normal.
The results above 50mg/l mean hyperalbuminemia occurs.
This is one of the basic laboratory parameters for assessing the body's nutritional status.
|
18 months
|
C-reactive protein (CRP) concentration in blood, based on laboratory analysis
Periodo de tiempo: 18 months
|
C-reactive protein concentration in blood is a laboratory parameter, measured in unit of mg/l.
The results below 5 mg/l are considered normal.
The results above 5mg/l mean infection, trauma, stress or other aggravating factor.
This is the major laboratory parameter for assessing homeostatic balance.
|
18 months
|
Efficacy of protein supplementation assessed on the Subjective Global Assessment (SGA) scale.
Periodo de tiempo: 18 months
|
Subjective global assessment (SGA) is the gold standard for diagnosing malnutrition.
SGA is a simple bedside questionnaire method used to diagnose malnutrition and identify those who would benefit from nutrition care.
The assessment includes taking a history of recent intake, weight change, gastrointestinal symptoms and a clinical evaluation.
Results are on a scale from 1 to 7. Values 1 and 2 means high risk of malnutririon, from 3 do 5 medium risk, and from 6 do 7 mild risk.
|
18 months
|
Efficacy of vitamin D and calcium supplementation assessed on the Simple Calculated Osteoporosis Risk Estimation (SCORE) scale.
Periodo de tiempo: 18 months
|
Simple Calculated Osteoporosis Risk Estimation (SCORE) scale is the questionnaire tool for diagnosing Osteoporosis risk.
It has been reported to appropriately identify person who should be referred for bone densitometry.
Results are on a scale from 0 to 50 points.
Points from 16 to 50 means high risk of osteoporosis , points from 7 to 15 moderate risk and from 0 do 6 low risk of osteoporosis.
|
18 months
|
Acceptability of physical activity based on Duke Activity Status Index (DASI) scale.
Periodo de tiempo: 18 months
|
The Duke Activity Status Index is a self-administered questionnaire that measures a patient's functional capacity.
It can be used to get a rough estimate of a patient's peak oxygen uptake.
Results are on a scale from 0 to 57,95 points.
The higher the score, the more intense the acceptable physical activity.
|
18 months
|
Incidence of cardiovascular hazard based on Cardiac Risk Index for Orthopedic Surgery (Lee) scale.
Periodo de tiempo: 18 months
|
Cardiac Risk Index for Orthopedic Surgery (Lee) is the questionnaire tool for diagnosing cardiovascular hazard in orthopedics patients.
Results are on a scale from 0 to 6 points.
Points from 3 to 6 means estimated risk of 4%, 2 points is 2,3% of risk, 1 point is 1,7% of risk and 0 points means less than 1 % of cardiovascular event.
|
18 months
|
Unwillingness of phisical activity due to pain based on Fear Avoidance Beliefs Questionnaire (FABQ) scale.
Periodo de tiempo: 18 months
|
Fear Avoidance Beliefs Questionnaire (FABQ) scale is a questionnaire based on the Fear-Avoidance Model of Exaggerated Pain Perception, a model created in attempts to explain why some patients with acute painful conditions can recover while other patients develop chronic pain from such conditions.
The FABQ focuses specifically on how a patient's fear-avoidance beliefs about physical activity and work.
It consists of 16 questions scaled form 0 do 6, higher score indicates fear avoidance behaviors.
|
18 months
|
The Quality of Life based on The Quality of Life (QOLS) scale.
Periodo de tiempo: 18 months
|
The Quality of Life (QOLS) scale is the most known scale measures factors like satisfaction, perceptions of control, involvement, commitment, and work-life balance, in terms of one's personal perception.
QOLS has 16 items, scaled form 1 do 7, higher score indicates superior appraisal of each aspect of life.
|
18 months
|
Incidence of Treatment-Emergent Adverse Events (AE) as assessed by frequency.
Periodo de tiempo: 18 months
|
Incidence of Adverse Events (AE) was summed up and analyzed in each group. They were divided into 7 groups.
|
18 months
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
- Procesos Patológicos
- Complicaciones Postoperatorias
- Dolor
- Manifestaciones neurológicas
- Trastornos Nutricionales
- Enfermedades Articulares
- Enfermedades musculoesqueléticas
- Enfermedades reumáticas
- Artritis
- Avitaminosis
- Enfermedades por deficiencia
- Desnutrición
- Osteoartritis
- Dolor Postoperatorio
- Artrosis, Rodilla
- Deficiencia de vitamina D
Otros números de identificación del estudio
- KBET/271/B/2014
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Intervention group 1
-
Amasya UniversityAún no reclutandoSoledad | Danzaterapia | Auto abandonoPavo
-
University of OxfordOxford University Hospitals NHS TrustDesconocidoSíntomas de comportamientoReino Unido
-
University of LisbonAssociacao Protectora dos Diabeticos de PortugalTerminado
-
Munich Municipal HospitalTechnical University of Munich; University of RegensburgDesconocido
-
Shiraz University of Medical SciencesTerminado
-
Heidelberg UniversityDesconocidoRetraso de idioma | Trastornos del desarrollo del lenguajeAlemania
-
University of PecsMedical University of PecsTerminado
-
Arizona Oncology ServicesDesconocidoCáncer de mama localizado | Cáncer de próstata localizado | Pacientes que reciben radioterapia de haz externoEstados Unidos
-
Ottawa Heart Institute Research CorporationCanadian Institutes of Health Research (CIHR)Activo, no reclutandoDependencia a la nicotina, cigarrillos | Abstinencia de nicotinaCanadá
-
University of MichiganReuben Phoenix Schostak Fontan Wellness Project FundReclutamientoFragilidad | Fisiología de Fontan | Enfermedad cardíaca de ventrículo únicoEstados Unidos